Then, if you try another GLP-1 in the future, it might not work, she says
Currently there are several selective DDP4 inhibitors approved for use in the US by the US FDA
The Problems with Current GLP-1 Guidelines Traditional medicine waits to prescribe GLP-1 medications until a patients BMI hits 30 (obesity) or 27 with at least one weight-related health condition, such as high blood pressure or high cholesterol
Only reason for 4 stars is I wish there were more female health products, but they said it's expanding soon
These symptoms are often temporary and tend to subside as your body adjusts to the treatment
Nestle, meanwhile, launched a brand called Vital Pursuits, targeting GLP-1 users and offering smaller portions, in May 2024